These success, together with a preceding report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 guidance the thought of focusing on ACKR3 as a novel way to modulate the opioid procedure, which could open new therapeutic avenues for opioid-relevant disorders. Importantly, these receptors were discovered https://anneh234yoa3.bloggerswise.com/profile